What Researchers Did
Researchers studied 11 patients with bisphosphonate-associated jawbone osteonecrosis to compare imaging results with tissue analysis after extensive hyperbaric oxygen therapy and surgical removal.
What They Found
The study found that computerized tomography (CT) scans revealed increased bone density, periosteal reaction, and bone sequestration in advanced stages of the condition. Magnetic resonance imaging (MRI) showed that exposed diseased bone had low water content, correlating with few cells and vessels, while unexposed diseased bone had high water content and inflammation, correlating with increased cells and blood vessels. These imaging findings correlated well with the histopathologic examination of the tissue.
What This Means for Canadian Patients
For Canadian patients experiencing bisphosphonate-associated jawbone osteonecrosis, this study suggests that CT and MRI scans are valuable tools for accurately assessing the extent of the disease, even beyond what is visible in the mouth. This detailed imaging can help doctors plan more effective treatments, potentially improving outcomes for those suffering from this painful condition.
Canadian Relevance
The study itself was not conducted in Canada, nor does it involve Canadian authors. However, bisphosphonate-associated jawbone osteonecrosis is a condition that can affect Canadian patients. While hyperbaric oxygen therapy was used in this study, it is not currently a Health Canada-recognized indication for this specific condition.
Study Limitations
A limitation of this study is its small sample size of only eleven patients, which may limit the generalizability of the findings.